Critical Reviews in Oncology/Hematology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.2 | Q1 | 86.4% | 1.977 | Q1 | 95.1% |
| 2024 | 5.6 | Q1 | 85.9% | 1.820 | Q1 | 94.4% |
| 2023 | 5.5 | Q1 | 79.0% | 1.572 | Q1 | 93.2% |
| 2022 | 6.2 | Q1 | 80.3% | 1.510 | Q1 | 93.1% |
| 2021 | 6.6 | Q2 | 79.0% | 1.478 | Q1 | 93.0% |
| 2020 | — | — | 2.084 | Q1 | 95.9% | |
| 2019 | — | — | 2.213 | Q1 | 96.4% | |
| 2018 | — | — | 1.791 | Q1 | 94.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1879-0461
ISSN
1040-8428
country
IEcoverage
1983-2026